2024-11-25 LIDR Meeting Notes

Date

Nov 25, 2024

Attendees

Name	Organization

Name	Organization
Hung Luu	Children’s
Riki Merrick	Vernetzt, APHL
Andrea Pitkus	UW
Pam Banning	3M - Solventum
Xavier Gansel	Biomerieux
Amy McCormick	Epic
Dan Rutz	Epic
Rob Rae	CAP
Rob Hausam	Hausam Consulting
Sandy Jones	CDC
Stan Huff	Graphite
Ed Heierman	Abbott / IICC
Andrew Quinn
Laurent Lardin	Biomerieux
Anthony Killeen	UMN
Craig Collom
Marti Velezis	Sonrisa / FDA
Walter Sujansky	FDA
Susan Downer	JMC
Ralf Herzog	Roche
Cornelia Felder	Roche
Daniel Golson	JMC
Andrea Prada	JMC
Maria Sagat	CAP
Raja Cholan	FDA
Russ Ott	FDA
Akila Namasivayam	FDA
Desiree Mustaquim	CDC
Carmen Pugh	CDC
Christina Gallegos	APHL
John Spinosa	Lantana
Matthew Dietz	FDA

Agenda and Notes

Topic	Notes

Topic	Notes
Call Schedule	send OOO via chat or email
LIDR White Paper Review	Reviewing the comments on the LIDR White Paper = LIDR White Paper Discussion: Added Title replaced “class” of LOINCs with set of LOINCs talked about the EBV study - cited was done on LDTs, while follow up done on FDA approved tests found less variations, decided to keep older reference in, but adjust sentence to include the newer study - talked about the fact that since we know of the vairation most organizations have policy to not merge results form different labs Update figure 6 to differentiate between kind (LIDR) and instnadce data going from labs to all its users = add box for LIS/LIMS in Clinical Laboratory boc and make different style arrows out of that to EHR-s and make research and PH systems instead of organizations add a bi-directional arrow between LDIR and Trusted Certification body to allow updates to LIDR based on lab LOINC coding observed during certification, that is deemed allowable - example would be timed tests that may not be in the manufacturer provided LIDR input Open To Dos: Update reference style to use the numbers with reference Section (Riki has that prepped) Reviewed comments on introduction - Still need to check for best place to talk about CLSI AUTO-16/IHE LAW (question: has anyone implemented in the US in production?) Andrea to write up her sentences as per comments GOAL: Get to SC for their 12/3 call!!!
Review examples of merged cell LIVD file entries	https://aphlinformatics.atlassian.net/wiki/download/attachments/1938718763/Copy-HIV-Diagnostic-LOINC-Map_v5.xlsx?api=v2 essentially the repeating cells were merged for readability, they all would be separate LIVD file entries with the same UDI
Reviewing minutes from the last call - Action Item Follow up	Pull out the definitions from LIVD for test kit and equipment and put here: SHIELD Glossary Review operational definition of “equivalence” Outreach to Dr. DeBaca Hung will check for more info and maybe see, if she could participate in SHIELD Keep updating the googlesheet: Potassium LIVD data Shared Reportable Conditions LIVD google sheet for crowdsourcing with CSTE - added sign up sheet for PHAs to specific conditions and see how that develops Have LIVD File Repository Requirements Have draft budget (for setting up a web-based database and yearly maintenance): https://aphlinformatics.atlassian.net/wiki/download/attachments/915407143/LIDR - Budget.xlsx?api=v2 Define next steps to migrate existing LIVD files into FHIR LIVD catalog format and find a FHIR server to host Marti can share the LIDR categorical data to instance data mapping for each element - DATE?
ACTION ITEMS
Next call	Monday 12/02/2024 9:05 - 9:55 AM ET
Adjourned	9:53 AM ET

Action items

Quick decisions not requiring context or tracking

For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.

Decisions requiring context or tracking

For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.